These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34122571)

  • 21. Optimized stereotactic volumetric modulated arc therapy as an alternative to brachytherapy for vaginal cuff boost. A dosimetric study.
    Cilla S; Macchia G; Mattiucci G; Ianiro A; Romano C; Buwenge M; Azario L; Valentini V; Deodato F; Morganti AG
    Med Dosim; 2020 Winter; 45(4):352-358. PubMed ID: 32565068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
    Hsu IC; Pickett B; Shinohara K; Krieg R; Roach M; Phillips T
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):851-8. PubMed ID: 10705005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high-dose-rate brachytherapy (HDR-BT) as a boost.
    Chicheł A; Kanikowski M; Skowronek J; Dymnicka M; Piotrowski T
    J Contemp Brachytherapy; 2009 Mar; 1(1):11-17. PubMed ID: 27799948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate.
    Lachance B; Béliveau-Nadeau D; Lessard E; Chrétien M; Hsu IC; Pouliot J; Beaulieu L; Vigneault E
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):86-100. PubMed ID: 12182978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer.
    Wazer DE; Lowther D; Boyle T; Ulin K; Neuschatz A; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):107-11. PubMed ID: 11316552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric analysis of breast cancer tumor bed boost: An interstitial brachytherapy vs. external beam radiation therapy comparison for deeply seated tumors.
    Shahbazian H; Bakhshali R; Shamsi A; Bagheri A
    Brachytherapy; 2020; 19(2):264-274. PubMed ID: 31787575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
    Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.
    Mikell JK; Klopp AH; Gonzalez GM; Kisling KD; Price MJ; Berner PA; Eifel PJ; Mourtada F
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e417-22. PubMed ID: 22436788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
    Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
    Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
    Lin L; Patel RR; Thomadsen BR; Henderson DL
    Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.
    Sharma R; Jursinic PA
    Med Phys; 2013 Jul; 40(7):071730. PubMed ID: 23822434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric impact of source-positioning uncertainty in high-dose-rate balloon brachytherapy of breast cancer.
    Kim Y
    J Contemp Brachytherapy; 2015 Oct; 7(5):387-96. PubMed ID: 26622246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric impact of applying a model-based dose calculation algorithm for skin cancer brachytherapy (interventional radiotherapy).
    Placidi E; Fionda B; Rosa E; Lancellotta V; Napolitano A; Angeli M; Pastore F; Gambacorta MA; Indovina L; Tagliaferri L; Spirito M
    J Contemp Brachytherapy; 2023 Dec; 15(6):448-452. PubMed ID: 38230401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of heterogeneity-corrected dose calculation using a grid-based Boltzmann solver on breast and cervix cancer brachytherapy.
    Hofbauer J; Kirisits C; Resch A; Xu Y; Sturdza A; Pötter R; Nesvacil N
    J Contemp Brachytherapy; 2016 Apr; 8(2):143-9. PubMed ID: 27257419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
    Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
    Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.
    Nicolae A; Murgic J; Kruljac I; Dubnitzky L; D'Alimonte L; Lu L; Cumal A; Law N; Morton G; Loblaw A; Chung HT; Ravi A
    Brachytherapy; 2018; 17(2):306-312. PubMed ID: 29239812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric impact of an 192Ir brachytherapy source cable length modeled using a grid-based Boltzmann transport equation solver.
    Mikell JK; Mourtada F
    Med Phys; 2010 Sep; 37(9):4733-43. PubMed ID: 20964191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.